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Screening Procedures
All participants completed an entrance questionnaire, the Pittsburgh Sleep Quality Index (PSQI), the Horne Ostberg Morningness Eveningness Questionnaire (HO) and the Beck Depression Inventory (BDI). Only non-pregnant women and men over age 18 years who did not cross more than two time zones within the last three months and who did not work on night shifts during the last 12 months were considered for participation in the study. All study participants came to the eye hospital (Hôpital Ophtalmique Jules Gonin, Lausanne, Switzerland) for an interview and underwent a baseline ophthalmologic examination which included best-corrected visual acuity, color vision testing with Ishihara book and non-dilated funduscopy.
Visual fields were assessed using threshold automated perimetry of the central 30 degrees (Octopus 101, Interzeag, Bern-Köniz, Switzerland). The macula and peripapillary retinal nerve fiber layer (RNFL) was examined by optical coherence tomography (OCT; Stratus 3000, Carl Zeiss, Meditec, Inc., Dublin, CA). Glaucoma patients previously treated with trabeculectomy were excluded due to potential effect on iris structure and pupillary movement. Patients using topical agents with known effects on pupillary function, e.g. pilocarpine, brimonidine were also excluded. Diabetes and other neurologic deficit, for example hearing loss were exclusionary factors. A total of 1100 medical charts were screened for inclusion in the study. Due to the rigorous exclusionary criteria, only 50 patients were identified as potential study participants and were invited to fill out questionnaires and to undergo an ophthalmological examination. Twenty five of those patients agreed to participate in the study. Two patients did not complete the study due to acute sickness and one patient was excluded retrospectively due to current use of pain pills and alcohol abuse which were not stated at the time of interview. A total of 11 patients with hereditary optic nerve disease and 11 glaucoma patients were included in the final data analysis.
Ophthalmologic patients
The 11 HON patients were four women and seven men aged 21 to 64 years (39.4 ± 15.2 years; mean ± SD; Table 1 ). None was taking a centrally acting medication. None of the HON patients was an extreme morning type, and PSQI scores ranged from 1 to 7 (4.4 ± 2.0), with three patients having PSQI scores greater than 5. The BDI was on average 1.7 ± 1.8 and ranged from 0 to 5. In 7 patients, results of gene testing were available from chart review. Three patients had a mutation of mitochondrial DNA associated with Leber hereditary optic neuropathy. In S4 two patients with a primary point mutation, 1 had double mutation at position 14484 and position 15257 and 1 patient had mutation at position 3460. The third patient had a non-primary mitochondrial DNA mutation. Four patients had genetic analysis for both Leber hereditary optic neuropathy and dominant optic atrophy and in 3, the results were reported as negative whereas the fourth patient had a point mutation on the short arm of chromosome 3 but the specific OPA1 gene mutation that accounts for two-thirds of patients with dominant optic atrophy was not found.
Visual acuity of HON patients ranged from 0.01 to 1.0 (0.4 ± 0.3; for all eyes; mean ± SD), one patient could count fingers at a distance of 2 m -his acuity was 0.01). All HON patients demonstrated bilateral, symmetric central visual field deficits with a mean deviation (MD) ranging from -1.8 to 17.8 db (7.3 ± 5.4 db). All HON patients had bilateral and symmetric optic atrophy; in three patients the pallor appeared confined to the temporal side of the optic disc. The mean peripapillary RNFL was 63.9 ±.10.5 μm (range from 26 to 94 μm).
The GL patient group consisted of eight women and 3 men whose age ranged from 40 to 63 years (54.1 ± 7.1 years; mean ± SD; Table 1 ). Two patients were extreme morning types (HO scores>70); the PSQI scores ranged from 1 to 11 (mean ± SD: 5.5 ± 3.8) with four scores > 5, indicating some sleep related problems in these patients. The BDI was on average 2.1 ± 1.9 and range from 0 to 7. Visual acuity (VA) ranged from 0.05 and 1.0 (0.7 ± 0.2). Mean deviation (MD) ranged from 1.7 db to 24.2 db (11.4 ± 6.2) and mean peripapillary RNFL in the OCT was 59.8 ± 16.5 μm (range: 35 to 95 μm).
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Age-matched controls
For the control group, healthy non-smoking volunteers were recruited via flyers in the region of Lausanne (Switzerland). Controls were matched to patients' age (± 3 years). All control participants were without psychiatric, medical or ocular disorders and not taking any prescription or non-prescription medications on a regular basis.
For control subjects, the inclusionary criteria from questionnaires included a PSQI to be lower or equal 5 (to exclude any sleep disorders), an HO score between 30 and 70 (to exclude extreme chronotypes) and a BDI less than 10 (to exclude for depression). All age-matched control participants had to have a normal ophthalmologic examination with no evidence of previous or current ocular disease other than refractive error. All controls had visual acuity of 1.0 or better (1.1 ± 0.1) and identified all 13 Ishihara color plates independently with each eye. The visual field of each control was judged to be normal and the MD for all controls ranged from -2.5 to 0.7 db (mean ± SD: -0.7 ± 0.8 db). Similarly, the OCT of controls was read as normal and the peripapillary RNFL measured 100.5 ± 11.3 μm, mean ± SD (range 68 to 125 μm). The HON control group ranged from 19 to 59 years and was composed of eight women, 3 men (age: 36.2 ± 13.2 years). The GL control group ranged from 42 to 63 years, with seven women and four men (54.4 ± 7.2 years). The demographic and ophthalmologic features of the patients and controls are presented in Table 1 .
Methods
Salivary melatonin
Salivary samples for melatonin assays were obtained every hour and then immediately stored at 4° C. After study completion, the samples were centrifuged and frozen at -20° C before sending them to an external laboratory for radio-immunoassays (RIA; Dr. B. Middleton; University of Surrey; Guildford; UK). The inter-assay S6 coefficients of variance were 12.4% (low) and 8.5% (high). The intra-assay coefficients of variance were 6.9 % (low) and 2.4% (high) with a detection limit of 0.6 pg/ml.
Pupillometry
The computerized pupillography was performed twice under dim light conditions (one hour after the study began and immediately before bright light exposure), and once There was no statistical difference between left and right eye pupil size (p>0.27 patients and p>0.1 controls), therefore pupil data from both eyes were averaged in all analyses. This was done to account for any potential differences that might occur from a difference in baseline pupil size, e.g. anisocoria. For two GL patients, eye movement artifacts precluded using data from one eye. A total of 6.4 % . In this task, the participant heard single tones and had to press the space key on the laptop as quickly as possible. A maximum of 50 tones were presented in random intervals. For the analysis, median reaction time (RT) and the 10% fastest and 10% slowest RT per trial were analyzed. Lapses, defined as RT > 500 ms were calculated separately, and RTs < 150 ms (anticipation) were not included in the analysis. The second performance test, the auditory n-back 6 was completed every two hours (five sessions). In this task, participants had to respond to spoken letters by pressing keys for correct or incorrect answers. In the 0-back test, the correct answer was when the participant heard the letter 'K' and pressed 'yes'; in the 2-back test the participant had to press 'yes' when the current letter which was played to the participant was identical with the penultimate one, otherwise the S9 participant had to press 'no'. In the 3-back test the participant had to press 'yes' if the current letter which was played to the participant was the same as the third last one, 
